BLRX

BIOLINE RX LIMITED

BLRX·09071M304·US·ADR·Healthcare - Biotechnology-13D/G

BLRX (BIOLINE RX LIMITED) is held by 11 institutional investors as of Q1 2026. Largest holders: XTX Topco Ltd ($25,274), RHUMBLINE ADVISERS ($5,432), BNP PARIBAS FINANCIAL MARKETS ($4,140). Net institutional sentiment: Bearish.

11
Holders
Avg rating(4 Elite)
$44,649
Total Value
29% (13)
Fund Consensus
2 buying - 5 selling
BLRXSmart Money Verdict
View all
Held by 11 funds
4 elite
Who's Trading
ActivistHIHighbridge Capital Management, LLC7.2%Aug 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
10,941$25,2740.0%+9.96%
27
Decreased
2,353(-29.8%)$5,4320.0%-79.74%
0
Increased
1,800(+20.0%)$4,1400.0%+8.04%
12
Unchanged
1,750$4,0250.0%-92.21%
0
Decreased
1,728(-15.2%)$3,9920.0%+7.67%
0
Decreased
529(-72.9%)$1,2170.0%-17.82%
0
Unchanged
107$2470.0%-88.09%
0
Unchanged
100$2300.0%-65.80%
0
Unchanged
26$590.0%+5.46%
0
Unchanged
12$280.0%-17.82%
0
Unchanged
2$50.0%+1.31%
0
Exited
0(-100.0%)$280.0%-3.30%
0
Exited
0(-100.0%)$104,4550.0%-14.76%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used